


Sirolimus is an immunosuppressant drug used either in addition to Cyclosporine or Tacrolimus or as a substitute in patients intolerant to these drugs. This assay monitors Sirolimus concentration during therapy particularly in individuals co-administered CYP3A4 substrates, inhibitors or inducers. The assay helps to evaluate patient compliance, adjust dose to optimize immunosuppression while minimizing toxicity.